Nexium, Other Acid Reflux Drugs Get Updated Label Warnings After Public Citizen Petition
The FDA will add new label warnings about drug interactions and other possible side effects of heartburn drugs after a consumer watchdog group sued the agency.
Tag Archives: CellCept
-
-
Novartis Faces Myfortic Kickback Charges from Justice Dept.
The federal government has filed a lawsuit against Novartis Pharmaceuticals this week, claiming that the pharmaceutical company engaged in an illegal kickback scheme to sell its kidney transplant drug Myfortic.…
-
CellCept Pure Red Cell Aplasia Reports Lead to New Warnings
The FDA announced Friday that labeling for the organ transplant medication CellCept will be changed to add warnings that the drug could cause a type of anemia known as Pure…
-
CellCept Lawsuits
In November 2007, a black boxed warning was added to the organ transplant medication about an increased risk of birth defects, such as cleft palate, cleft lip and ear deformities,…
-
Kidney Transplant Drugs Receive New Warnings About Infection Side Effects
The FDA is requiring new warnings on several immunosuppressant drugs designed to prevent renal transplant patients from rejecting new kidneys. The new labeling will warn users of potential side effects…
-
Warning Added for Progressive Multifocal Leukoencephalopathy to CellCept and Myfortic
Roche and Novartis have added warnings to their organ transplant medications, CellCept and Myfortic, indicating an association with Progressive Multifocal Leukoencephalopathy, a rare and potentially fatal neurological condition.
-
Myfortic Lawsuits
In November 2007, the FDA added a black boxed warning about possible Myfortic side effects which could increase the risk of birth defects and malformations. According to reports, pregnant women…
-
FDA Warns of Myfortic and CellCept Birth Defect Risks
On Friday, the FDA posted an alert on their website to provide additional information to doctors about the possible risk of miscarriages and birth defects associated with the use of…
